HOSPITAL UNIVERSITARIO RUBER
Departamento
University Medical Center Hamburg-Eppendorf
Hamburgo, AlemaniaPublicaciones en colaboración con investigadores/as de University Medical Center Hamburg-Eppendorf (7)
2023
-
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer
Annals of Oncology, Vol. 34, Núm. 8, pp. 645-659
2022
-
Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases: Final Results From the Phase 3 ATTAIN Randomized Clinical Trial
JAMA Oncology, Vol. 8, Núm. 7, pp. 1047-1052
2021
-
Expert Discussion: Highlights from the San Antonio Breast Cancer Symposium, San Antonio, December 8-11, 2020
Breast Care
-
Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial
The Lancet Oncology, Vol. 22, Núm. 4, pp. 499-511
2020
-
ASCO 2020
Breast Care
-
Oncological care organisation during COVID-19 outbreak
ESMO Open, Vol. 5, Núm. 4
2019
-
ATTAIN: Phase III study of etirinotecan pegol versus treatment of physician's choice in patients with metastatic breast cancer and brain metastases
Future Oncology, Vol. 15, Núm. 19, pp. 2211-2225